RxDoctor Payments Data

Derek Benz, PA

Physician Assistant · Springfield, MONPI 1033703624

Payments from drug & device makers

$4,326in general payments, 2019–2025

Across 153 payments — averaging $28.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Lilly USA, LLC$458
  • Johnson & Johnson$424
  • Novo Nordisk$329
  • Daiichi Sankyo Inc.$226
  • AstraZeneca$162
  • plus $1K from 20 others

What the payments were for

  • Travel & lodging$1,17727%
  • Food & beverage$3,14973%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,326 in reported general payments places this provider in the 90th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$32,810
Medicare patients
206
Services billed
3,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin53$37,872
EliquisApixaban28$30,126
FarxigaDapagliflozin Propanediol33$28,135
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$20,469
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$10,150
MyrbetriqMirabegron16$9,046
LinzessLinaclotide13$6,942
Albuterol Sulfate HfaAlbuterol Sulfate46$1,040
Gabapentin97$1,027
Losartan Potassium87$732
Pantoprazole Sodium76$716
Atorvastatin Calcium141$655
Metoprolol Succinate70$618
Pravastatin Sodium56$603
Rosuvastatin Calcium42$596

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$162$48,60465 claims
Boehringer IngelheimJardiance$150$37,87253 claims
PfizerEliquis$121$30,12628 claims
GSKTrelegy Ellipta$133$10,15014 claims
Astellas Pharma US IncMyrbetriq$17$9,04616 claims
AbbVieLinzess$112$6,94213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →